19 completed, 2 unknown, 1 active not recruiting. 22 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 19, Unknown 2, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Dong-A ST Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control DA5221-T1, DA5221-T2, Placebo - Type 2 Diabetes | Phase 3 | Active not recruiting | Dong-A ST Co., Ltd. | 174 | 2024-04-01 | 2025-11-19 |
| Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis DA-5219, Stillen® Tab, DA-5219 Placebo - Gastritis Acute, Gastritis Chronic | Phase 3 | Completed | Dong-A ST Co., Ltd. | 467 | 2024-01-31 | 2025-08-28 |
| Clinical Trial of DA-5212 in Patients with Functional Dyspepsia DA-5212, DA-5212-R - Functional Dyspepsia | Phase 3 | Completed | Dong-A ST Co., Ltd. | 384 | 2023-06-06 | 2024-12-13 |
| A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder DA-8010 Placebo, DA-8010 2.5mg, DA-8010 5mg - Overactive Bladder | Phase 3 | Completed | Dong-A ST Co., Ltd. | 607 | 2022-05-12 | 2024-06-26 |
| Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis DMB-3115, Stelara - Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | Completed | Dong-A ST Co., Ltd. | 598 | 2021-04-28 | 2024-01-18 |
| Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control Dapagliflozin 10mg, Placebo, Evogliptin 5mg - Type 2 Diabetes | Phase 3 | Completed | Dong-A ST Co., Ltd. | 198 | 2020-05-26 | 2022-03-22 |
| Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control Evogliptin 5mg, Evogliptin Placebo, Dapagliflozin 10mg - Type2 Diabetes | Phase 3 | Completed | Dong-A ST Co., Ltd. | 283 | 2020-01-02 | 2021-12-10 |
| Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients DA-2802, Viread® - Hepatitis B， Chronic | Phase 3 | Completed | Dong-A ST Co., Ltd. | 123 | 2017-03-28 | 2021-04-14 |
| A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients Leucostim 5µg/kg/day, Neupogen 5µg/kg/day - Breast Cancer | Phase 3 | Completed | Dong-A ST Co., Ltd. | 143 | 2017-01-12 | 2020-12-28 |
| Efficacy of DA-5204 on Gastroesophageal Reflux Disease Pantoprazole, DA-5204, Placebo - Esophageal Disease | Phase 3 | Completed | Seoul National University Hospital | 70 | 2016-06-01 | 2019-06-26 |
| To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex) EPORON, EPREX - Anemia of Chronic Kidney Disease | Phase 3 | Unknown | Dong-A ST Co., Ltd. | 214 | 2016-03-01 | 2019-12-10 |
| Efficacy and Safety of DA-3002 in Short Children Borns SGA. DA-3002, Genotropin® - Infant, Small for Gestational Age | Phase 3 | Completed | Dong-A ST Co., Ltd. | 75 | 2016-02-26 | 2019-10-16 |
| The Effect of Naftopidil for the Double-J Stent Discomfort Naftopidil, Placebo for Naftopidil, Standard treatment - Disorder of Urinary Stent | Phase 3 | Completed | Seoul National University Hospital | 100 | 2014-05-01 | 2015-12-10 |
| Medical Expulsive Therapy for Ureter Stone Using Naftopidil Naftopidil 75mg, Placebo for Naftopidil, Standard treatment - Ureter Stones | Phase 3 | Completed | Seoul National University Hospital | 150 | 2014-05-01 | 2015-12-10 |
| A Study to Evaluate the Efficacy and Safety of DA-5204 DA-5204, Stillen tab. - Acute Gastritis, Chronic Gastritis | Phase 3 | Unknown | Dong-A ST Co., Ltd. | 434 | 2014-04-01 | 2014-11-04 |
| Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH Udenafil - Pulmonary Arterial Hypertension | Phase 2 / Phase 3 | Completed | Dong-A ST Co., Ltd. | 59 | 2014-04-01 | 2016-04-18 |
| A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin evogliptin 5mg, Placebo - Type 2 Diabetes Mellitus | Phase 3 | Completed | Dong-A ST Co., Ltd. | 160 | 2013-07-01 | 2017-03-28 |
| Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes evogliptin, Sitagliptin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Dong-A ST Co., Ltd. | 222 | 2013-05-01 | 2016-10-31 |
| A Clinical Study to Assess the Efficacy and Safety of DA-3002 DA-3002, Genotropin® - Turner's Syndrome | Phase 3 | Completed | Dong-A ST Co., Ltd. | 58 | 2013-02-01 | 2018-07-26 |
| Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature DA-3002 - Idiopathic Short Stature | Phase 3 | Completed | Dong-A ST Co., Ltd. | 70 | 2012-02-01 | 2017-10-19 |
Showing 20 of 22. Sign in to see all of them.
Diabetes Mellitus, Type 2 (4) · Anovulation (1) · Breast Neoplasms (1) · Dwarfism (1) · Esophageal Diseases (1) · Esophagitis, Peptic (1) · Gastroesophageal Reflux (1) · Hepatitis B, Chronic (1) · Infertility (1) · Neutropenia (1) · Pulmonary Arterial Hypertension (1) · Turner Syndrome (1) · Urinary Bladder, Overactive (1)
4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (4) · DA 9601 (2) · DA-5204 (2) · Human Growth Hormone (2) · dapagliflozin (2) · naftopidil (2) · Analgesia (1) · DA-3801 (1) · DA-8010 (1) · Epoetin Alfa (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Growth Hormone (1) · Metformin (1) · Pantoprazole (1)
South Korea (18) · Indonesia (1) · Turkey (Türkiye) (1) · United States (1)
Byung Kyu Suh, M.D., Ph.D. (2) · Chang Jong Kim, M.D., Ph.D. (2) · Chang Wook Jeong, M.D., Ph.D. (2) · Cheol Woo Ko, M.D., Ph.D. (2) · Choong Ho Shin, M.D., Ph.D. (2) · Han Wook Yoo, M.D., Ph.D. (2) · Heon Suk Han, M.D., Ph.D. (2) · Ho Seong Kim, M.D., Ph.D. (2) · Jin Soon Hwang, M.D., Ph.D. (2) · Kee Hyoung Lee, M.D., Ph.D. (2) · Woo Young Jeong, M.D., Ph.D. (2) · Byungkyu Suh, MD (1) · Chang Suk Suh, M.D., Ph.D. (1) · Chanjong Kim, MD (1) · Cheolwoo Ko, MD (1)
PMID 28960033, PMID 34397702, PMID 34893062, PMID 35315603, PMID 37750183, PMID 39223856